PubMed:3524231 / 0-178 JSONTXT

Annnotations TAB JSON ListView MergeView

    DisGeNET

    {"project":"DisGeNET","denotations":[{"id":"T0","span":{"begin":46,"end":60},"obj":"gene:2688"},{"id":"T1","span":{"begin":13,"end":40},"obj":"disease:C0013264"}],"relations":[{"id":"R1","pred":"associated_with","subj":"T0","obj":"T1"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"Treatment of Duchenne muscular dystrophy with growth hormone inhibitors.\nA controlled, double-blind therapeutic trial with the drug mazindol, a growth hormone inhibitor, was perf"}

    sentences

    {"project":"sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":72},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":72},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Treatment of Duchenne muscular dystrophy with growth hormone inhibitors.\nA controlled, double-blind therapeutic trial with the drug mazindol, a growth hormone inhibitor, was perf"}

    PubCasesHPO

    {"project":"PubCasesHPO","denotations":[{"id":"TI1","span":{"begin":22,"end":40},"obj":"HP:0003560"}],"text":"Treatment of Duchenne muscular dystrophy with growth hormone inhibitors.\nA controlled, double-blind therapeutic trial with the drug mazindol, a growth hormone inhibitor, was perf"}

    PubCasesORDO

    {"project":"PubCasesORDO","denotations":[{"id":"TI1","span":{"begin":13,"end":40},"obj":"ORDO:98896"}],"namespaces":[{"prefix":"ORDO","uri":"http://www.orpha.net/ORDO/Orphanet_"}],"text":"Treatment of Duchenne muscular dystrophy with growth hormone inhibitors.\nA controlled, double-blind therapeutic trial with the drug mazindol, a growth hormone inhibitor, was perf"}

    NCBIDiseaseCorpus

    {"project":"NCBIDiseaseCorpus","denotations":[{"id":"T1","span":{"begin":13,"end":40},"obj":"SpecificDisease:D020388"}],"text":"Treatment of Duchenne muscular dystrophy with growth hormone inhibitors.\nA controlled, double-blind therapeutic trial with the drug mazindol, a growth hormone inhibitor, was perf"}

    NCBI-Disease-Train

    {"project":"NCBI-Disease-Train","denotations":[{"id":"T3448","span":{"begin":13,"end":40},"obj":"SpecificDisease"}],"attributes":[{"id":"A3448","pred":"database_id","subj":"T3448","obj":"D020388"}],"text":"Treatment of Duchenne muscular dystrophy with growth hormone inhibitors.\nA controlled, double-blind therapeutic trial with the drug mazindol, a growth hormone inhibitor, was perf"}

    NCBI-Disease-Corpus-All

    {"project":"NCBI-Disease-Corpus-All","denotations":[{"id":"T3448","span":{"begin":13,"end":40},"obj":"SpecificDisease"}],"attributes":[{"id":"A3448","pred":"database_id","subj":"T3448","obj":"D020388"}],"text":"Treatment of Duchenne muscular dystrophy with growth hormone inhibitors.\nA controlled, double-blind therapeutic trial with the drug mazindol, a growth hormone inhibitor, was perf"}

    NCBI-Disease-Corpus-2stage-All

    {"project":"NCBI-Disease-Corpus-2stage-All","denotations":[{"id":"T1","span":{"begin":13,"end":40},"obj":"SpecificDisease"}],"text":"Treatment of Duchenne muscular dystrophy with growth hormone inhibitors.\nA controlled, double-blind therapeutic trial with the drug mazindol, a growth hormone inhibitor, was perf"}

    NCBI-Disease-Corpus-rezarta-All

    {"project":"NCBI-Disease-Corpus-rezarta-All","denotations":[{"id":"T1","span":{"begin":13,"end":40},"obj":"SpecificDisease"}],"text":"Treatment of Duchenne muscular dystrophy with growth hormone inhibitors.\nA controlled, double-blind therapeutic trial with the drug mazindol, a growth hormone inhibitor, was perf"}

    NCBI-Disease-Corpus-4oGuideline-All

    {"project":"NCBI-Disease-Corpus-4oGuideline-All","denotations":[{"id":"T1","span":{"begin":13,"end":40},"obj":"SpecificDisease"}],"text":"Treatment of Duchenne muscular dystrophy with growth hormone inhibitors.\nA controlled, double-blind therapeutic trial with the drug mazindol, a growth hormone inhibitor, was perf"}

    NCBI-Disease-Corpus-Simple-All

    {"project":"NCBI-Disease-Corpus-Simple-All","denotations":[{"id":"T1","span":{"begin":13,"end":40},"obj":"SpecificDisease"},{"id":"T2","span":{"begin":46,"end":71},"obj":"CompositeMention"},{"id":"T3","span":{"begin":144,"end":168},"obj":"CompositeMention"}],"text":"Treatment of Duchenne muscular dystrophy with growth hormone inhibitors.\nA controlled, double-blind therapeutic trial with the drug mazindol, a growth hormone inhibitor, was perf"}